Duke Cancer Center
Durham, North Carolina, 27710, United States
NCT Number: NCT04371198
The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion
Exclusion
Tissue biopsy
Time frame: Baseline
Duke University
Other
Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03345563
Bladder Cancer, Colon Cancer
New Brunswick, New Jersey, United States
View Trial DetailsNCT02738359
Colon Cancer, Colonic Diseases
Pessac, Aquitaine, France
View Trial DetailsNCT06950996
Breast Cancer, Breast Diseases
Valencia, Spain
View Trial DetailsNCT04015804
Colorectal Neoplasms, Digestive System Diseases
Brussels, Belgium
View Trial Details